Company: CI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001739940-25-000009
Chunk: 503

Company: Cigna Group
Filing Date: 2025-02-27
Form: 10-K
Item: Item 5
Chunk 503
---
 declared (per share: $4.92)(1,452)(1,452)(1,452)Repurchase of common stock(2,282)(2,282)(2,282)Other transactions impacting noncontrolling interests(41)(41)(20)(61)(139)Balance at December 31, 2023$4 $30,669 $(1,864)$41,652 $(24,238)$46,223 $21 $46,244 $107 Effect of issuing stock for employee benefit plans619 (120)499 499 Other comprehensive loss(477)(477)(477)— Net income3,434 3,434 344 3,778 — Common dividends declared (per share: $5.60)(1,567)(1,567)(1,567)Repurchase of common stock— (7,079)(7,079)(7,079)Other transactions impacting noncontrolling interests— — (155)(155)(107)Balance at December 31, 2024$4 $31,288 $(2,341)$43,519 $(31,437)$41,033 $210 $41,243 $— 

The accompanying Notes to the Consolidated Financial Statements are an integral part of these statements.

60

The Cigna Group

Consolidated Statements of Cash FlowsFor the Years Ended December 31,(In millions)202420232022Cash Flows from Operating ActivitiesNet income$3,778 $5,372 $6,782 Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization2,775 3,035 2,937 Investment losses, net2,737 78 487 Deferred income tax benefit(95)(1,659)(472)Net (gain) loss on sale of businesses(24)1,499 (1,662)Net changes in assets and liabilities, net of non-operating effects:Accounts receivable, net(7,369)(1,663)(2,237)Inventories(1,032)(868)(1,055)Reinsurance recoverable and Other assets(485)(539)393 Insurance liabilities(591)584 (336)Pharmacy and other service costs payable8,757 2,030 1,760 Accounts payable and Accrued expenses and other liabilities1,138